HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study - Ateşoğlu, Elif Birtaş; Murat Özbalak; Olga Meltem Akay; Mustafa Pehlıvan; Birol Yıldız; Ant Uzay; Tuğçe Nur Yiğenoğlu; Tuğrul Elverdi; Leylagül Kaynar; Orhan Ayyıldız; İpek Yönal Hindilerden; Hasan Sami Göksoy; et al. (My University, 2021)
Keywords: Medicine; Brentuximab vedotin; Salvage therapy; Autologous stem-cell transplantation; Internal medicine; Surgery; Regimen; Transplantation; Clinical endpoint; Context (archaeology); Oncology; Lymphoma; Clinical trial; Chemotherapy; Hodgkin lymphoma; 3